Fundamental Pharma GmbH

Germany

Create a watch for Fundamental Pharma GmbH
Total IP 11
Total IP Rank # 142,146
IP Activity Score 1.6/5.0    6
IP Activity Rank # 157,527

Patents

Trademarks

3 0
3 0
5 0
0
 
Last Patent 2024 - Effective means to modulate nmda...
First Patent 2012 - Vegf-d/vegfr2/3-mediated regulat...

Latest Inventions, Goods, Services

2024 Invention Effective means to modulate nmda receptor-mediated toxicity. The present invention relates to com...
2021 Invention Novel means to predict and manipulate nmda receptor-mediated toxicity. The present invention rel...
Invention Novel means to predict and manipulate nmda receptor-mediated toxicity. The present invention rela...
2019 Invention Novel means to modulate nmda receptor-mediated toxicity. The present invention relates to the fi...
2018 Invention Novel means to modulate nmda receptor-mediated toxicity. The present invention relates to the fie...
2012 Invention Vegf-d/vegfr2/3-mediated regulation of dendrites. The present invention relates to methods for mo...